TICAM1: A Potential Drug Target and Biomarker for TIR-Containing Adapter Proteins

Target Name: TICAM1

NCBI ID: G148022

TICAM1: A Potential Drug Target and Biomarker for TIR-Containing Adapter Proteins

Introduction

The TIR (Toll-Induced Generation of IFN-尾) domain is a unique protein that has been identified in various cellular processes, including DNA replication, gene expression, and cell signaling pathways. TIR domains are known to play a crucial role in the regulation of intracellular signaling pathways, and their involvement in various cellular processes has led to the discovery of numerous potential drug targets and biomarkers. One such protein is TICAM1 (TIR domain-containing adapter protein), which has been shown to induce the production of IFN- 尾, a critical cytokine involved in immune and inflammatory responses.

IFN-尾 is a cytokine that plays a crucial role in the immune response against infections and diseases. When an invading pathogen enters the body, it triggers an immune response, which involves the production of IFN-尾 by various immune cells, including T cells , NK cells, and macrophages. IFN-尾 is a pro-inflammatory cytokine that promotes the recruitment of immune cells to the site of infection or inflammation, triggers the production of other cytokines, and modulates the immune response by regulating the activity of immune cells.

TICAM1: A Potential Drug Target

TICAM1 is a protein that was identified as a potential drug target for the treatment of various diseases due to its involvement in the regulation of IFN-尾 production. TICAM1 is a transmembrane protein that is expressed in various tissues and cells, including the liver, lung , heart, kidney, and pancreas. It is characterized by a long N-terminus that contains a TIR domain, which is responsible for its unique function in regulating the production of IFN-尾.

The TIR domain is a unique protein that is characterized by a specific domain that contains a leucine-rich repeat (LRR) and a short alpha-helix. The LRR is a common structural motif that is found in various proteins, including enzymes, adapter proteins , and transmembrane proteins. The LRR functions as a binding site for other proteins, including intracellular signaling molecules, which can modulate the activity of these proteins. The alpha-helix is 鈥嬧?媋 structural motif that is found in many proteins and is responsible for the stability and localization of various proteins.

TICAM1 has been shown to induce the production of IFN-尾 by various cellular processes. For instance, TICAM1 has been shown to induce the production of IFN-尾 by human keratinocytes, which are a type of cancer cell that can be used to study the effects of various drugs on cancer growth. Additionally, TICAM1 has been shown to induce the production of IFN-尾 by human airway epithelial cells, which are responsible for the regulation of airway responses to various irritants, including particles and bacteria.

TICAM1 has also been shown to play a role in the regulation of inflammation, which is a critical part of the immune response. TICAM1 has also been shown to modulate the activity of various immune cells, including T cells and macrophages, which are involved in the regulation of inflammation. Additionally, TICAM1 has been shown to regulate the production of pro-inflammatory cytokines, which are involved in the regulation of inflammation.

TICAM1 as a Potential Biomarker

TICAM1 has also been shown to serve as a potential biomarker for various diseases. For instance, TICAM1 has been shown to be involved in the regulation of the production of IFN-尾, which is a critical cytokine involved in the regulation of immune and inflammatory responses . This suggests that TICAM1 may be a useful biomarker for the diagnosis and treatment of diseases that are characterized by inflammation or immune dysfunction.

In addition to its potential role as a drug target, TICAM1 also has the potential to serve as a biomarker for various diseases. For instance, TICAM1 has been shown to be involved in the regulation of the production of IFN-尾, which is a critical cytokine involved in the regulation of immune and inflammatory responses. This suggests that TICAM1 may be a useful biomarker for

Protein Name: TIR Domain Containing Adaptor Molecule 1

Functions: Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis (PubMed:12471095, PubMed:12539043, PubMed:14739303, PubMed:28747347). Ligand binding to these receptors results in TRIF recruitment through its TIR domain (PubMed:12471095, PubMed:12539043, PubMed:14739303). Distinct protein-interaction motifs allow recruitment of the effector proteins TBK1, TRAF6 and RIPK1, which in turn, lead to the activation of transcription factors IRF3 and IRF7, NF-kappa-B and FADD respectively (PubMed:12471095, PubMed:12539043, PubMed:14739303). Phosphorylation by TBK1 on the pLxIS motif leads to recruitment and subsequent activation of the transcription factor IRF3 to induce expression of type I interferon and exert a potent immunity against invading pathogens (PubMed:25636800). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of pro-inflammatory cytokines (By similarity)

More Common Targets